カテゴリ： 世界, IT/電子, QYResearch

若年性特発性関節炎治療薬の世界市場2023年：経口式、皮下式

■ 英語タイトル：Global Juvenile Idiopathic Arthritis Therapeutics Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA8800）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA8800
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：88
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[若年性特発性関節炎治療薬の世界市場2023年：経口式、皮下式]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査資料は若年性特発性関節炎治療薬のグローバル市場について調査・分析し、世界の若年性特発性関節炎治療薬市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（経口式、皮下式）、用途別セグメント分析（病院、診療所、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Johnson & Johnson Services, Inc.、Novartis International AG、Bristol-Myers Squibb、Zydus Cadila、Takeda Pharmaceutical Company Limited、Genentech, Inc.、Latona Life Sciences.などが含まれています。若年性特発性関節炎治療薬のグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、若年性特発性関節炎治療薬市場規模を算出する際に考慮しました。

・若年性特発性関節炎治療薬市場の概要
- 若年性特発性関節炎治療薬の種類別セグメント
- 世界の若年性特発性関節炎治療薬市場規模：タイプ別分析（経口式、皮下式）
- 若年性特発性関節炎治療薬の用途別セグメント
- 世界の若年性特発性関節炎治療薬市場規模：用途別分析（病院、診療所、その他）
- 世界の若年性特発性関節炎治療薬市場規模予測（2018年-2029年）

・若年性特発性関節炎治療薬市場の成長トレンド
- 若年性特発性関節炎治療薬の地域別市場規模（2018年-2029年）
- 若年性特発性関節炎治療薬市場ダイナミクス
- 若年性特発性関節炎治療薬の業界動向
- 若年性特発性関節炎治療薬市場の成長ドライバ、課題、阻害要因

・主要企業別競争状況
- 企業別市場シェア
- 世界の主要企業、業界ランキング分析
- 市場への参入、M＆A動向

・種類別セグメント：経口式、皮下式
- 世界の若年性特発性関節炎治療薬のタイプ別市場規模（2018年-2023年）
- 世界の若年性特発性関節炎治療薬のタイプ別市場規模（2024年-2029年）

・用途別セグメント：病院、診療所、その他
- 世界の若年性特発性関節炎治療薬の用途別市場規模（2018年-2023年）
- 世界の若年性特発性関節炎治療薬の用途別市場規模（2024年-2029年）

・若年性特発性関節炎治療薬の地域別市場規模
- 北米の若年性特発性関節炎治療薬市場規模（2018年-2029年）
- 米国の若年性特発性関節炎治療薬市場規模（2018年-2029年）
- ヨーロッパの若年性特発性関節炎治療薬市場規模（2018年-2029年）
- アジア太平洋の若年性特発性関節炎治療薬市場規模（2018年-2029年）
- 中国の若年性特発性関節炎治療薬市場規模（2018年-2029年）
- 日本の若年性特発性関節炎治療薬市場規模（2018年-2029年）
- 韓国の若年性特発性関節炎治療薬市場規模（2018年-2029年）
- インドの若年性特発性関節炎治療薬市場規模（2018年-2029年）
- オーストラリアの若年性特発性関節炎治療薬市場規模（2018年-2029年）
- 中南米の若年性特発性関節炎治療薬市場規模（2018年-2029年）
- 中東・アフリカの若年性特発性関節炎治療薬市場規模（2018年-2029年）

・主要企業のプロファイル：企業情報、事業概要、売上、動向
Johnson & Johnson Services, Inc.、Novartis International AG、Bristol-Myers Squibb、Zydus Cadila、Takeda Pharmaceutical Company Limited、Genentech, Inc.、Latona Life Sciences.

・アナリストの観点/結論

・調査手法と情報源

Highlights
The global Juvenile Idiopathic Arthritis Therapeutics market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Juvenile Idiopathic Arthritis Therapeutics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Juvenile Idiopathic Arthritis Therapeutics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Juvenile Idiopathic Arthritis Therapeutics in Hospital is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Juvenile Idiopathic Arthritis Therapeutics include Johnson & Johnson Services, Inc., Novartis International AG, Bristol-Myers Squibb, Zydus Cadila, Takeda Pharmaceutical Company Limited, Genentech, Inc. and Latona Life Sciences., etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Juvenile Idiopathic Arthritis Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Juvenile Idiopathic Arthritis Therapeutics.
The Juvenile Idiopathic Arthritis Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Juvenile Idiopathic Arthritis Therapeutics market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Juvenile Idiopathic Arthritis Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Johnson & Johnson Services, Inc.
Novartis International AG
Bristol-Myers Squibb
Zydus Cadila
Takeda Pharmaceutical Company Limited
Genentech, Inc.
Latona Life Sciences.
Segment by Type
Oral
Subcutaneous
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Juvenile Idiopathic Arthritis Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Juvenile Idiopathic Arthritis Therapeutics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Oral
1.2.3 Subcutaneous
1.3 Market by Application
1.3.1 Global Juvenile Idiopathic Arthritis Therapeutics Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Juvenile Idiopathic Arthritis Therapeutics Market Perspective (2018-2029)
2.2 Juvenile Idiopathic Arthritis Therapeutics Growth Trends by Region
2.2.1 Global Juvenile Idiopathic Arthritis Therapeutics Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Juvenile Idiopathic Arthritis Therapeutics Historic Market Size by Region (2018-2023)
2.2.3 Juvenile Idiopathic Arthritis Therapeutics Forecasted Market Size by Region (2024-2029)
2.3 Juvenile Idiopathic Arthritis Therapeutics Market Dynamics
2.3.1 Juvenile Idiopathic Arthritis Therapeutics Industry Trends
2.3.2 Juvenile Idiopathic Arthritis Therapeutics Market Drivers
2.3.3 Juvenile Idiopathic Arthritis Therapeutics Market Challenges
2.3.4 Juvenile Idiopathic Arthritis Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Juvenile Idiopathic Arthritis Therapeutics Players by Revenue
3.1.1 Global Top Juvenile Idiopathic Arthritis Therapeutics Players by Revenue (2018-2023)
3.1.2 Global Juvenile Idiopathic Arthritis Therapeutics Revenue Market Share by Players (2018-2023)
3.2 Global Juvenile Idiopathic Arthritis Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Juvenile Idiopathic Arthritis Therapeutics Revenue
3.4 Global Juvenile Idiopathic Arthritis Therapeutics Market Concentration Ratio
3.4.1 Global Juvenile Idiopathic Arthritis Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Juvenile Idiopathic Arthritis Therapeutics Revenue in 2022
3.5 Juvenile Idiopathic Arthritis Therapeutics Key Players Head office and Area Served
3.6 Key Players Juvenile Idiopathic Arthritis Therapeutics Product Solution and Service
3.7 Date of Enter into Juvenile Idiopathic Arthritis Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Juvenile Idiopathic Arthritis Therapeutics Breakdown Data by Type
4.1 Global Juvenile Idiopathic Arthritis Therapeutics Historic Market Size by Type (2018-2023)
4.2 Global Juvenile Idiopathic Arthritis Therapeutics Forecasted Market Size by Type (2024-2029)
5 Juvenile Idiopathic Arthritis Therapeutics Breakdown Data by Application
5.1 Global Juvenile Idiopathic Arthritis Therapeutics Historic Market Size by Application (2018-2023)
5.2 Global Juvenile Idiopathic Arthritis Therapeutics Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Juvenile Idiopathic Arthritis Therapeutics Market Size (2018-2029)
6.2 North America Juvenile Idiopathic Arthritis Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Juvenile Idiopathic Arthritis Therapeutics Market Size by Country (2018-2023)
6.4 North America Juvenile Idiopathic Arthritis Therapeutics Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Juvenile Idiopathic Arthritis Therapeutics Market Size (2018-2029)
7.2 Europe Juvenile Idiopathic Arthritis Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Juvenile Idiopathic Arthritis Therapeutics Market Size by Country (2018-2023)
7.4 Europe Juvenile Idiopathic Arthritis Therapeutics Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Juvenile Idiopathic Arthritis Therapeutics Market Size (2018-2029)
8.2 Asia-Pacific Juvenile Idiopathic Arthritis Therapeutics Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Juvenile Idiopathic Arthritis Therapeutics Market Size by Region (2018-2023)
8.4 Asia-Pacific Juvenile Idiopathic Arthritis Therapeutics Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Juvenile Idiopathic Arthritis Therapeutics Market Size (2018-2029)
9.2 Latin America Juvenile Idiopathic Arthritis Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Juvenile Idiopathic Arthritis Therapeutics Market Size by Country (2018-2023)
9.4 Latin America Juvenile Idiopathic Arthritis Therapeutics Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Juvenile Idiopathic Arthritis Therapeutics Market Size (2018-2029)
10.2 Middle East & Africa Juvenile Idiopathic Arthritis Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Juvenile Idiopathic Arthritis Therapeutics Market Size by Country (2018-2023)
10.4 Middle East & Africa Juvenile Idiopathic Arthritis Therapeutics Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Johnson & Johnson Services, Inc.
11.1.1 Johnson & Johnson Services, Inc. Company Detail
11.1.2 Johnson & Johnson Services, Inc. Business Overview
11.1.3 Johnson & Johnson Services, Inc. Juvenile Idiopathic Arthritis Therapeutics Introduction
11.1.4 Johnson & Johnson Services, Inc. Revenue in Juvenile Idiopathic Arthritis Therapeutics Business (2018-2023)
11.1.5 Johnson & Johnson Services, Inc. Recent Development
11.2 Novartis International AG
11.2.1 Novartis International AG Company Detail
11.2.2 Novartis International AG Business Overview
11.2.3 Novartis International AG Juvenile Idiopathic Arthritis Therapeutics Introduction
11.2.4 Novartis International AG Revenue in Juvenile Idiopathic Arthritis Therapeutics Business (2018-2023)
11.2.5 Novartis International AG Recent Development
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Detail
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb Juvenile Idiopathic Arthritis Therapeutics Introduction
11.3.4 Bristol-Myers Squibb Revenue in Juvenile Idiopathic Arthritis Therapeutics Business (2018-2023)
11.3.5 Bristol-Myers Squibb Recent Development
11.4 Zydus Cadila
11.4.1 Zydus Cadila Company Detail
11.4.2 Zydus Cadila Business Overview
11.4.3 Zydus Cadila Juvenile Idiopathic Arthritis Therapeutics Introduction
11.4.4 Zydus Cadila Revenue in Juvenile Idiopathic Arthritis Therapeutics Business (2018-2023)
11.4.5 Zydus Cadila Recent Development
11.5 Takeda Pharmaceutical Company Limited
11.5.1 Takeda Pharmaceutical Company Limited Company Detail
11.5.2 Takeda Pharmaceutical Company Limited Business Overview
11.5.3 Takeda Pharmaceutical Company Limited Juvenile Idiopathic Arthritis Therapeutics Introduction
11.5.4 Takeda Pharmaceutical Company Limited Revenue in Juvenile Idiopathic Arthritis Therapeutics Business (2018-2023)
11.5.5 Takeda Pharmaceutical Company Limited Recent Development
11.6 Genentech, Inc.
11.6.1 Genentech, Inc. Company Detail
11.6.2 Genentech, Inc. Business Overview
11.6.3 Genentech, Inc. Juvenile Idiopathic Arthritis Therapeutics Introduction
11.6.4 Genentech, Inc. Revenue in Juvenile Idiopathic Arthritis Therapeutics Business (2018-2023)
11.6.5 Genentech, Inc. Recent Development
11.7 Latona Life Sciences.
11.7.1 Latona Life Sciences. Company Detail
11.7.2 Latona Life Sciences. Business Overview
11.7.3 Latona Life Sciences. Juvenile Idiopathic Arthritis Therapeutics Introduction
11.7.4 Latona Life Sciences. Revenue in Juvenile Idiopathic Arthritis Therapeutics Business (2018-2023)
11.7.5 Latona Life Sciences. Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Juvenile Idiopathic Arthritis Therapeutics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Oral
Table 3. Key Players of Subcutaneous
Table 4. Global Juvenile Idiopathic Arthritis Therapeutics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Juvenile Idiopathic Arthritis Therapeutics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Juvenile Idiopathic Arthritis Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Juvenile Idiopathic Arthritis Therapeutics Market Share by Region (2018-2023)
Table 8. Global Juvenile Idiopathic Arthritis Therapeutics Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Juvenile Idiopathic Arthritis Therapeutics Market Share by Region (2024-2029)
Table 10. Juvenile Idiopathic Arthritis Therapeutics Market Trends
Table 11. Juvenile Idiopathic Arthritis Therapeutics Market Drivers
Table 12. Juvenile Idiopathic Arthritis Therapeutics Market Challenges
Table 13. Juvenile Idiopathic Arthritis Therapeutics Market Restraints
Table 14. Global Juvenile Idiopathic Arthritis Therapeutics Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Juvenile Idiopathic Arthritis Therapeutics Market Share by Players (2018-2023)
Table 16. Global Top Juvenile Idiopathic Arthritis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Juvenile Idiopathic Arthritis Therapeutics as of 2022)
Table 17. Ranking of Global Top Juvenile Idiopathic Arthritis Therapeutics Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Juvenile Idiopathic Arthritis Therapeutics Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Juvenile Idiopathic Arthritis Therapeutics Product Solution and Service
Table 21. Date of Enter into Juvenile Idiopathic Arthritis Therapeutics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Juvenile Idiopathic Arthritis Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Juvenile Idiopathic Arthritis Therapeutics Revenue Market Share by Type (2018-2023)
Table 25. Global Juvenile Idiopathic Arthritis Therapeutics Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Juvenile Idiopathic Arthritis Therapeutics Revenue Market Share by Type (2024-2029)
Table 27. Global Juvenile Idiopathic Arthritis Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Juvenile Idiopathic Arthritis Therapeutics Revenue Market Share by Application (2018-2023)
Table 29. Global Juvenile Idiopathic Arthritis Therapeutics Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Juvenile Idiopathic Arthritis Therapeutics Revenue Market Share by Application (2024-2029)
Table 31. North America Juvenile Idiopathic Arthritis Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Juvenile Idiopathic Arthritis Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Juvenile Idiopathic Arthritis Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Juvenile Idiopathic Arthritis Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Juvenile Idiopathic Arthritis Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Juvenile Idiopathic Arthritis Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Juvenile Idiopathic Arthritis Therapeutics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Juvenile Idiopathic Arthritis Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Juvenile Idiopathic Arthritis Therapeutics Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Juvenile Idiopathic Arthritis Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Juvenile Idiopathic Arthritis Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Juvenile Idiopathic Arthritis Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Juvenile Idiopathic Arthritis Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Juvenile Idiopathic Arthritis Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Juvenile Idiopathic Arthritis Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 46. Johnson & Johnson Services, Inc. Company Detail
Table 47. Johnson & Johnson Services, Inc. Business Overview
Table 48. Johnson & Johnson Services, Inc. Juvenile Idiopathic Arthritis Therapeutics Product
Table 49. Johnson & Johnson Services, Inc. Revenue in Juvenile Idiopathic Arthritis Therapeutics Business (2018-2023) & (US$ Million)
Table 50. Johnson & Johnson Services, Inc. Recent Development
Table 51. Novartis International AG Company Detail
Table 52. Novartis International AG Business Overview
Table 53. Novartis International AG Juvenile Idiopathic Arthritis Therapeutics Product
Table 54. Novartis International AG Revenue in Juvenile Idiopathic Arthritis Therapeutics Business (2018-2023) & (US$ Million)
Table 55. Novartis International AG Recent Development
Table 56. Bristol-Myers Squibb Company Detail
Table 57. Bristol-Myers Squibb Business Overview
Table 58. Bristol-Myers Squibb Juvenile Idiopathic Arthritis Therapeutics Product
Table 59. Bristol-Myers Squibb Revenue in Juvenile Idiopathic Arthritis Therapeutics Business (2018-2023) & (US$ Million)
Table 60. Bristol-Myers Squibb Recent Development
Table 61. Zydus Cadila Company Detail
Table 62. Zydus Cadila Business Overview
Table 63. Zydus Cadila Juvenile Idiopathic Arthritis Therapeutics Product
Table 64. Zydus Cadila Revenue in Juvenile Idiopathic Arthritis Therapeutics Business (2018-2023) & (US$ Million)
Table 65. Zydus Cadila Recent Development
Table 66. Takeda Pharmaceutical Company Limited Company Detail
Table 67. Takeda Pharmaceutical Company Limited Business Overview
Table 68. Takeda Pharmaceutical Company Limited Juvenile Idiopathic Arthritis Therapeutics Product
Table 69. Takeda Pharmaceutical Company Limited Revenue in Juvenile Idiopathic Arthritis Therapeutics Business (2018-2023) & (US$ Million)
Table 70. Takeda Pharmaceutical Company Limited Recent Development
Table 71. Genentech, Inc. Company Detail
Table 72. Genentech, Inc. Business Overview
Table 73. Genentech, Inc. Juvenile Idiopathic Arthritis Therapeutics Product
Table 74. Genentech, Inc. Revenue in Juvenile Idiopathic Arthritis Therapeutics Business (2018-2023) & (US$ Million)
Table 75. Genentech, Inc. Recent Development
Table 76. Latona Life Sciences. Company Detail
Table 77. Latona Life Sciences. Business Overview
Table 78. Latona Life Sciences. Juvenile Idiopathic Arthritis Therapeutics Product
Table 79. Latona Life Sciences. Revenue in Juvenile Idiopathic Arthritis Therapeutics Business (2018-2023) & (US$ Million)
Table 80. Latona Life Sciences. Recent Development
Table 81. Research Programs/Design for This Report
Table 82. Key Data Information from Secondary Sources
Table 83. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Juvenile Idiopathic Arthritis Therapeutics Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Juvenile Idiopathic Arthritis Therapeutics Market Share by Type: 2022 VS 2029
Figure 3. Oral Features
Figure 4. Subcutaneous Features
Figure 5. Global Juvenile Idiopathic Arthritis Therapeutics Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Juvenile Idiopathic Arthritis Therapeutics Market Share by Application: 2022 VS 2029
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Others Case Studies
Figure 10. Juvenile Idiopathic Arthritis Therapeutics Report Years Considered
Figure 11. Global Juvenile Idiopathic Arthritis Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Juvenile Idiopathic Arthritis Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Juvenile Idiopathic Arthritis Therapeutics Market Share by Region: 2022 VS 2029
Figure 14. Global Juvenile Idiopathic Arthritis Therapeutics Market Share by Players in 2022
Figure 15. Global Top Juvenile Idiopathic Arthritis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Juvenile Idiopathic Arthritis Therapeutics as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Juvenile Idiopathic Arthritis Therapeutics Revenue in 2022
Figure 17. North America Juvenile Idiopathic Arthritis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Juvenile Idiopathic Arthritis Therapeutics Market Share by Country (2018-2029)
Figure 19. United States Juvenile Idiopathic Arthritis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada Juvenile Idiopathic Arthritis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Juvenile Idiopathic Arthritis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Juvenile Idiopathic Arthritis Therapeutics Market Share by Country (2018-2029)
Figure 23. Germany Juvenile Idiopathic Arthritis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France Juvenile Idiopathic Arthritis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. Juvenile Idiopathic Arthritis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy Juvenile Idiopathic Arthritis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia Juvenile Idiopathic Arthritis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries Juvenile Idiopathic Arthritis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Juvenile Idiopathic Arthritis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Juvenile Idiopathic Arthritis Therapeutics Market Share by Region (2018-2029)
Figure 31. China Juvenile Idiopathic Arthritis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan Juvenile Idiopathic Arthritis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea Juvenile Idiopathic Arthritis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia Juvenile Idiopathic Arthritis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India Juvenile Idiopathic Arthritis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia Juvenile Idiopathic Arthritis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Juvenile Idiopathic Arthritis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Juvenile Idiopathic Arthritis Therapeutics Market Share by Country (2018-2029)
Figure 39. Mexico Juvenile Idiopathic Arthritis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil Juvenile Idiopathic Arthritis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Juvenile Idiopathic Arthritis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Juvenile Idiopathic Arthritis Therapeutics Market Share by Country (2018-2029)
Figure 43. Turkey Juvenile Idiopathic Arthritis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia Juvenile Idiopathic Arthritis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Johnson & Johnson Services, Inc. Revenue Growth Rate in Juvenile Idiopathic Arthritis Therapeutics Business (2018-2023)
Figure 46. Novartis International AG Revenue Growth Rate in Juvenile Idiopathic Arthritis Therapeutics Business (2018-2023)
Figure 47. Bristol-Myers Squibb Revenue Growth Rate in Juvenile Idiopathic Arthritis Therapeutics Business (2018-2023)
Figure 48. Zydus Cadila Revenue Growth Rate in Juvenile Idiopathic Arthritis Therapeutics Business (2018-2023)
Figure 49. Takeda Pharmaceutical Company Limited Revenue Growth Rate in Juvenile Idiopathic Arthritis Therapeutics Business (2018-2023)
Figure 50. Genentech, Inc. Revenue Growth Rate in Juvenile Idiopathic Arthritis Therapeutics Business (2018-2023)
Figure 51. Latona Life Sciences. Revenue Growth Rate in Juvenile Idiopathic Arthritis Therapeutics Business (2018-2023)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 関節リウマチ治療薬のグローバル市場展望 2023年-2029年：医薬品、バイオ医薬品
  • 関節リウマチ用医薬品のグローバル市場展望 2023年-2029年：医療用医薬品、一般用医薬品
  • 関節炎用手袋の世界市場2023年：冬用手袋、加圧手袋
  • ピーナッツアレルギー治療薬の世界市場2023年：エピネフリン注射、抗ヒスタミン薬、経口免疫療法、その他
  • 関節炎処方薬のグローバル市場展望 2023年-2029年：経口投与、局所投与
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA8800 )"若年性特発性関節炎治療薬の世界市場2023年：経口式、皮下式" (英文：Global Juvenile Idiopathic Arthritis Therapeutics Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。